Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Muscle Invasive”

519 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 519 results

Not applicableUnknownNCT02895620
What this trial is testing

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Who this might be right for
Non Muscle Invasive Bladder CancerTreatment by BCG
Institut Claudius Regaud 24
Testing effectiveness (Phase 2)UnknownNCT02075060
What this trial is testing

Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle-invasive Bladder Cancer
Poitiers University Hospital 54
Not applicableLooking for participantsNCT06972771
What this trial is testing

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle-Invasive Bladder Cancer
Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05975606
What this trial is testing

Non-invasive Brain Stimulation Paired With FES Cycling Post SCI

Who this might be right for
Incomplete Spinal Cord Injury
Western University, Canada 14
Early research (Phase 1)Study completedNCT05492734
What this trial is testing

Assess the Feasibility of Non-invasive Dried Blood Sampling

Who this might be right for
Muscular Dystrophies
Edgewise Therapeutics, Inc. 10
Not applicableStudy completedNCT03490214
What this trial is testing

Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography

Who this might be right for
Duchenne Muscular DystrophyMuscular DystrophiesMuscular Dystrophy, Duchenne
University of Erlangen-Nürnberg Medical School 20
Large-scale testing (Phase 3)UnknownNCT04859751
What this trial is testing

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Qilu Pharmaceutical Co., Ltd. 53
Testing effectiveness (Phase 2)Study completedNCT02625961
What this trial is testing

Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 296
Not applicableEnded earlyNCT06026332
What this trial is testing

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Who this might be right for
Bladder Cancer
Ferring Pharmaceuticals 202
Not applicableNot Yet RecruitingNCT04167332
What this trial is testing

Prospective Collection of Samples for Urothelial Cancer of Bladder

Who this might be right for
Bladder Cancer
Universitaire Ziekenhuizen KU Leuven 630
Testing effectiveness (Phase 2)Study completedNCT02343614
What this trial is testing

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Large-scale testing (Phase 3)UnknownNCT01225614
What this trial is testing

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

Who this might be right for
MyopathyMuscular WeaknessRespiratory Insufficiency
Assistance Publique - Hôpitaux de Paris 77
Testing effectiveness (Phase 2)Looking for participantsNCT07128602
What this trial is testing

Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction

Who this might be right for
Anterior Cruciate Ligament Reconstruction RehabilitationQuadriceps Muscle Function
Arcadia University 42
Testing effectiveness (Phase 2)Looking for participantsNCT03379909
What this trial is testing

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

Who this might be right for
Superficial Bladder CancerBladder Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableStudy completedNCT02169726
What this trial is testing

A Pilot Study Non-Invasive Guidance for Therapeutic Ultrasound Treatment of Lower Back Muscle Injuries

Who this might be right for
Injury; Muscle, Back, Lower
University of California, Irvine 5
Testing effectiveness (Phase 2)WithdrawnNCT02143804
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh GradeNon Muscle Invasive
CG Oncology, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06995677
What this trial is testing

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Low-grade NMIBCFGFR Gene AmplificationFGFR Gene Alterations+3 more
Tyra Biosciences, Inc 90
Early research (Phase 1)Looking for participantsNCT05519241
What this trial is testing

A Phase I Intravesical PPM Therapy for NMIBC

Who this might be right for
Non-muscle-invasive Bladder Cancer
VA Office of Research and Development 29
Load More Results